Director Julian Sluyters filed a Form 4 with the SEC on November 17, 2026, disclosing a purchase of 25,000 shares of common stock in Davion Healthcare PLC on November 16, 2026.

Key Highlights

  • Reporting person: Julian Sluyters, identified as a Director of Davion Healthcare PLC (NASDAQ:DAVI).
  • Transaction: Purchase (transaction code P) of 25,000 shares of common stock on November 16, 2026.
  • Price per share: $1.0596, as reported in the filing.
  • Resulting ownership: 30,000 shares of common stock beneficially owned directly following the transaction.
  • No derivative securities: Table II of the filing contains no reported derivative security transactions.

Sluyters Adds to Davion Healthcare Position in November 2026 Open-Market Purchase

According to the filing, Julian Sluyters, a director of Davion Healthcare PLC, acquired 25,000 shares of the company's common stock on November 16, 2026, at a price of $1.0596 per share. The transaction is recorded under transaction code P, indicating an open-market purchase. The filing was signed by Julian Sluyters and submitted to the SEC on November 17, 2026.

Following the reported transaction, the filing discloses that Sluyters beneficially owns a total of 30,000 shares of Davion Healthcare PLC common stock, held directly. No indirect ownership or derivative security positions are reported in the filing. Table II, covering derivative securities such as options, warrants, or convertible securities, contains no entries.

The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934 and covers a single non-derivative transaction. No amendment date is indicated, suggesting this is an original filing. Davion Healthcare PLC is listed on NASDAQ under the ticker symbol DAVI, as stated on the cover of the filing.

What Was Disclosed

Director Julian Sluyters reported the purchase of 25,000 shares of Davion Healthcare PLC common stock at $1.0596 per share on November 16, 2026, bringing his total direct beneficial ownership to 30,000 shares. No derivative securities were reported.